Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin

BACKGROUND: Preclinical and clinical research suggest that the α1 receptor antagonist prazosin reduces alcohol consumption. Furthermore, clinical studies indicate a role of prazosin in treating Post-Traumatic Stress Disorder (PTSD) symptoms, while a recent trial suggested that pre-treatment blood pr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Drug Alcohol Depend
Main Authors: Haass-Koffler, Carolina L., Goodyear, Kimberly, Zywiak, William H., Magill, Molly, Eltinge, Sarah E., Wallace, Paul M., Long, Victoria M., Jayaram-Lindström, Nitya, Swift, Robert M., Kenna, George A., Leggio, Lorenzo
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5534374/
https://ncbi.nlm.nih.gov/pubmed/28551590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2017.03.016
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki